ClinVar Genomic variation as it relates to human health
NM_000038.6(APC):c.2161_2170del (p.Gly721fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000038.6(APC):c.2161_2170del (p.Gly721fs)
Variation ID: 495355 Accession: VCV000495355.6
- Type and length
-
Deletion, 10 bp
- Location
-
Cytogenetic: 5q22.2 5: 112837753-112837762 (GRCh38) [ NCBI UCSC ] 5: 112173450-112173459 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Mar 17, 2018 Feb 20, 2024 May 4, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000038.6:c.2161_2170del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000029.2:p.Gly721fs frameshift NM_001127510.3:c.2161_2170del NP_001120982.1:p.Gly721fs frameshift NM_001127511.3:c.2107_2116del NP_001120983.2:p.Gly703fs frameshift NM_001354895.2:c.2161_2170del NP_001341824.1:p.Gly721fs frameshift NM_001354896.2:c.2215_2224del NP_001341825.1:p.Gly739fs frameshift NM_001354897.2:c.2191_2200del NP_001341826.1:p.Gly731fs frameshift NM_001354898.2:c.2086_2095del NP_001341827.1:p.Gly696fs frameshift NM_001354899.2:c.2077_2086del NP_001341828.1:p.Gly693fs frameshift NM_001354900.2:c.2038_2047del NP_001341829.1:p.Gly680fs frameshift NM_001354901.2:c.1984_1993del NP_001341830.1:p.Gly662fs frameshift NM_001354902.2:c.1888_1897del NP_001341831.1:p.Gly630fs frameshift NM_001354903.2:c.1858_1867del NP_001341832.1:p.Gly620fs frameshift NM_001354904.2:c.1783_1792del NP_001341833.1:p.Gly595fs frameshift NM_001354905.2:c.1681_1690del NP_001341834.1:p.Gly561fs frameshift NM_001354906.2:c.1312_1321del NP_001341835.1:p.Gly438fs frameshift NC_000005.10:g.112837755_112837764del NC_000005.9:g.112173452_112173461del NG_008481.4:g.150235_150244del LRG_130:g.150235_150244del - Protein change
- G561fs, G662fs, G693fs, G703fs, G438fs, G680fs, G721fs, G731fs, G739fs, G620fs, G696fs, G595fs, G630fs
- Other names
- -
- Canonical SPDI
- NC_000005.10:112837752:TGGGAAGTGCTG:TG
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
APC | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
14965 | 15103 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
criteria provided, single submitter
|
Jul 21, 2017 | RCV000589699.1 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
May 4, 2023 | RCV004562633.3 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jul 21, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Familial multiple polyposis syndrome
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV000694008.1
First in ClinVar: Mar 17, 2018 Last updated: Mar 17, 2018 |
Comment:
Variant summary: The c.2161_2170delGGAAGTGCTG (p.Gly721Glnfs) variant in APC gene is a frameshift change that results in the loss of the ~2123 amino acids of APC … (more)
Variant summary: The c.2161_2170delGGAAGTGCTG (p.Gly721Glnfs) variant in APC gene is a frameshift change that results in the loss of the ~2123 amino acids of APC protein (~75%). This change is predicted to cause loss of normal protein function through protein truncation or nonsense-mediated mRNA decay. The variant is absent from the large control population datasets of ExAC and gnomAD (120756 and 245146 chrs tested, respectively). The c.2161_2170delGGAAGTGCTG has not, to our knowledge, been reported in affected individuals via published reports or cited by reputable databases/clinical laboratories. Other overlapping truncated variants, such as c.2162delG and c.2169delT, have been reported in association with APC. Based on the location of this variant within exon 16, it is expected to result in classical FAP. Taken together, the variant was classified as Pathogenic. (less)
|
|
Pathogenic
(May 04, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Familial adenomatous polyposis 1
Affected status: unknown
Allele origin:
unknown
|
Myriad Genetics, Inc.
Accession: SCV004045189.2
First in ClinVar: Oct 21, 2023 Last updated: Oct 28, 2023 |
Comment:
This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.
|
|
Pathogenic
(Oct 13, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Familial adenomatous polyposis 1
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV002232062.3
First in ClinVar: Mar 28, 2022 Last updated: Feb 20, 2024 |
Comment:
This variant is expected to disrupt the EB1 and HDLG binding sites, which mediate interactions with the cytoskeleton (PMID: 15311282, 17293347). While functional studies have … (more)
This variant is expected to disrupt the EB1 and HDLG binding sites, which mediate interactions with the cytoskeleton (PMID: 15311282, 17293347). While functional studies have not been performed to directly test the effect on APC protein function, this suggests that disruption of the C-terminal portion of the protein is functionally important. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the APC protein in which other variant(s) (p.Tyr2645Lysfs*14) have been determined to be pathogenic (PMID: 1316610, 8381579, 9824584, 22135120, 27081525; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 495355). This variant has not been reported in the literature in individuals affected with APC-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gly721Glnfs*3) in the APC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 2123 amino acid(s) of the APC protein. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Attenuated familial adenomatous polyposis with desmoids caused by an APC mutation. | Ikenoue T | Human genome variation | 2015 | PMID: 27081525 |
Prevalence of skin lesions in familial adenomatous polyposis: a marker for presymptomatic diagnosis? | Burger B | The oncologist | 2011 | PMID: 22135120 |
Regulated binding of adenomatous polyposis coli protein to actin. | Moseley JB | The Journal of biological chemistry | 2007 | PMID: 17293347 |
EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration. | Wen Y | Nature cell biology | 2004 | PMID: 15311282 |
Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. | Brensinger JD | Gut | 1998 | PMID: 9824584 |
Mutational analysis of patients with adenomatous polyposis: identical inactivating mutations in unrelated individuals. | Groden J | American journal of human genetics | 1993 | PMID: 8381579 |
Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. | Miyoshi Y | Proceedings of the National Academy of Sciences of the United States of America | 1992 | PMID: 1316610 |
Text-mined citations for rs1554083981 ...
HelpRecord last updated Nov 03, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.